- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Smoldering Multiple Myeloma in New Zealand
Total 2222 results
-
Weill Medical College of Cornell UniversityCelgeneCompletedMultiple MyelomaUnited States
-
NYU Langone HealthMillennium Pharmaceuticals, Inc.TerminatedMultiple MyelomaUnited States
-
Siyang LengCompleted
-
Ajai ChariNovartis PharmaceuticalsCompletedMultiple MyelomaUnited States
-
Hearn Jay ChoBristol-Myers SquibbCompletedMultiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterAmgenCompletedMultiple MyelomaUnited States
-
Karyopharm Therapeutics IncActive, not recruitingAcute Myeloid Leukemia (AML) | Metastatic Colorectal Cancer (mCRC) | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Relapsed/Refractory Multiple Myeloma (RRMM) | Higher-Risk Myelodysplastic Syndrome (HR-MDS) | Newly Diagnosed Intermediate/High-Risk MDSUnited States, France, Canada, Spain, China
-
University of Michigan Rogel Cancer CenterCelgene; Onyx Therapeutics, Inc.CompletedMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterBeyondSpring Pharmaceuticals Inc.Active, not recruiting
-
Innate PharmaCompletedMultiple MyelomaUnited States
-
Icahn School of Medicine at Mount SinaiMemorial Sloan Kettering Cancer Center; Hackensack Meridian HealthCompletedFatigue | Multiple MyelomaUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruitingMultiple MyelomaAustralia
-
Yale UniversityGlaxoSmithKlineRecruitingMultiple MyelomaUnited States
-
Hackensack Meridian HealthAmgenRecruitingMultiple MyelomaUnited States
-
Hackensack Meridian HealthActive, not recruitingMultiple MyelomaUnited States
-
Hackensack Meridian HealthTerminatedMultiple MyelomaUnited States
-
Yale UniversityCompleted
-
Yale UniversityCelgene CorporationCompletedMultiple MyelomaUnited States
-
University of RochesterTerminatedMultiple MyelomaUnited States
-
SanofiRecruitingPlasma Cell MyelomaGermany, United States, Argentina, China, France, Hong Kong, Italy, Japan, Puerto Rico, Spain, Switzerland, United Arab Emirates, United Kingdom, Austria, Belgium, Netherlands, Taiwan
-
Carevive Systems, Inc.RecruitingBreast Cancer | Multiple Myeloma | Ovarian Cancer | Lung Cancer | Acute Myelogenous LeukemiaUnited States
-
ChimerixActive, not recruiting
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.Completed
-
Genzyme, a Sanofi CompanyAnorMEDTerminatedMultiple MyelomaUnited States
-
AttenuonTerminated
-
Hackensack Meridian HealthJanssen, LPTerminatedMultiple MyelomaUnited States
-
Hackensack Meridian HealthMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Hackensack Meridian HealthGenentech, Inc.TerminatedA Phase II Study of Bevacizumab and Bortezomib in Patients With Relapsed/Refractory Multiple MyelomaMultiple MyelomaUnited States
-
Hackensack Meridian HealthCompletedMultiple MyelomaUnited States
-
Hackensack Meridian HealthMerck Sharp & Dohme LLCCompletedMultiple MyelomaUnited States
-
Dartmouth-Hitchcock Medical CenterTerminatedMultiple MyelomaUnited States
-
Lava TherapeuticsActive, not recruitingAcute Myeloid Leukemia | Multiple Myeloma | Chronic Lymphocytic LeukemiaUnited States, Spain, France, Netherlands
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Celularity IncorporatedCompleted
-
Seagen Inc.Terminated
-
Weill Medical College of Cornell UniversityCelgene CorporationTerminated
-
Sorrento Therapeutics, Inc.Active, not recruitingMultiple MyelomaUnited States
-
Ludwig Institute for Cancer ResearchMemorial Sloan Kettering Cancer Center; Fox Chase Cancer Center; GlaxoSmithKline and other collaboratorsCompletedMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterColumbia University; Montefiore Medical Center; Weill Medical College of Cornell... and other collaboratorsCompleted
-
Thomas Martin, MDSanofi; AmgenActive, not recruitingMultiple MyelomaUnited States, Canada
-
Promontory Therapeutics Inc.CompletedMultiple MyelomaUnited States
-
University of NebraskaRecruiting
-
Astex Pharmaceuticals, Inc.Multiple Myeloma Research ConsortiumCompletedMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingMultiple Myeloma | Plasmacytoma | Plasmacytoma of BoneUnited States
-
SanofiRecruitingPlasma Cell Myeloma RecurrentUnited States, Argentina, Australia, Brazil, Canada, Chile, China, Czechia, France, Germany, Greece, Hungary, Italy, Japan, Norway, Poland, Spain, Sweden, Taiwan, Turkey, United Kingdom